Literature DB >> 9162203

Autoradiography with [3H]8-OH-DPAT reveals increases in 5-HT(1A) receptors in ventral prefrontal cortex in schizophrenia.

M D Simpson1, D I Lubman, P Slater, J F Deakin.   

Abstract

We previously reported increased glutamatergic innervation in orbital frontal cortex in schizophrenia. In view of the evidence that one serotonin (5-HT) receptor, the 5-HT(1A) subtype, is associated with cortical glutamatergic neurons, we have used quantitative receptor autoradiography to measure the specific binding of the 5-HT(1A) receptor ligand [3H]8-OH-DPAT (2 nM) in sections of orbital frontal cortex taken from 18 control and 12 schizophrenic postmortem brains. Schizophrenic patients, as compared with controls, had increased 5-HT(1A) receptor binding in the three orbital frontal regions examined. These effects were pronounced in the male subgroup, and were most apparent in the outer cortical laminae. These data are consistent with the hypothesis that schizophrenia is associated with an abnormal glutamatergic afferent innervation of orbital frontal cortex.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9162203     DOI: 10.1016/0006-3223(95)00026-7

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  21 in total

1.  Effects of repeated risperidone exposure on serotonin receptor subtypes in developing rats.

Authors:  Yong Kee Choi; Taylor Moran-Gates; Matthew P Gardner; Frank I Tarazi
Journal:  Eur Neuropsychopharmacol       Date:  2009-10-29       Impact factor: 4.600

2.  Prevention of the phencyclidine-induced impairment in novel object recognition in female rats by co-administration of lurasidone or tandospirone, a 5-HT(1A) partial agonist.

Authors:  Masakuni Horiguchi; Kayleen E Hannaway; Adesewa E Adelekun; Karu Jayathilake; Herbert Y Meltzer
Journal:  Neuropsychopharmacology       Date:  2012-06-27       Impact factor: 7.853

3.  Serotonin 1A receptor availability in patients with schizophrenia and schizo-affective disorder: a positron emission tomography imaging study with [11C]WAY 100635.

Authors:  W Gordon Frankle; Ilise Lombardo; Lawrence S Kegeles; Mark Slifstein; John H Martin; Yiyun Huang; Dah-Ren Hwang; Elisa Reich; Claudine Cangiano; Roberto Gil; Marc Laruelle; Anissa Abi-Dargham
Journal:  Psychopharmacology (Berl)       Date:  2006-09-05       Impact factor: 4.530

Review 4.  The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment.

Authors:  Herbert Y Meltzer; Masakuni Horiguchi; Bill W Massey
Journal:  Psychopharmacology (Berl)       Date:  2011-01-08       Impact factor: 4.530

5.  GABA Targets for the Treatment of Cognitive Dysfunction in Schizophrenia.

Authors:  David W Volk; David A Lewis
Journal:  Curr Neuropharmacol       Date:  2005-01       Impact factor: 7.363

6.  Autoradiographic evaluation of [3H]CUMI-101, a novel, selective 5-HT1AR ligand in human and baboon brain.

Authors:  J S Dileep Kumar; Ramin V Parsey; Suham A Kassir; Vattoly J Majo; Matthew S Milak; Jaya Prabhakaran; Norman R Simpson; Mark D Underwood; J John Mann; Victoria Arango
Journal:  Brain Res       Date:  2013-02-27       Impact factor: 3.252

7.  Gene expression in the anterior cingulate cortex and amygdala of adolescent marmoset monkeys following parental separations in infancy.

Authors:  Amanda J Law; Qi Pei; Joram Feldon; Christopher R Pryce; Paul J Harrison
Journal:  Int J Neuropsychopharmacol       Date:  2008-12-23       Impact factor: 5.176

8.  The biochemical womb of schizophrenia: A review.

Authors:  N Gaur; S Gautam; M Gaur; P Sharma; G Dadheech; S Mishra
Journal:  Indian J Clin Biochem       Date:  2008-12-20

9.  The kinesin superfamily protein KIF17: one protein with many functions.

Authors:  Margaret T T Wong-Riley; Joseph C Besharse
Journal:  Biomol Concepts       Date:  2012-06-01

10.  Expression of the PPM1F Gene Is Regulated by Stress and Associated With Anxiety and Depression.

Authors:  Aliza P Wingo; Eric R Velasco; Antonio Florido; Adriana Lori; Dennis C Choi; Tanja Jovanovic; Kerry J Ressler; Raül Andero
Journal:  Biol Psychiatry       Date:  2017-08-30       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.